Nannan Zhao

Nannan Zhao

Auto-generated profile, based on publicly available information

Nannan Zhao

School of Public Health, Nantong University, 9 Seyuan Rd, Nantong, 226019, PR China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2024 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
SZShaokai Zheng
Shaokai Zheng
JJJinchen Jiang
Jinchen Jiang
ZSZhenhao Shu
Zhenhao Shu
CQChong Qiu
Chong Qiu
LJLianlian Jiang
Lianlian Jiang
LQLianglin Qiu
Lianglin Qiu

15 February 2019 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
JYJunzhu Yi
Junzhu Yi
ZCZhenghua Chen
Zhenghua Chen
FXFenghuang Xu
Fenghuang Xu
ZWZhuoYa Wang
ZhuoYa Wang
AZAiping Zhang
Aiping Zhang
XLXiying Luan
Xiying Luan
Human mesenchymal stromal cells (MSCs) harbor immunomodulatory properties to induce the generation of suppressive T cells. MSCs have been successfully used in treating graft-versus-host disease (GVHD) accompanied by abundant inflammatory cytokines such as IL-27. This study investigated the effects of IL-27 on the human placenta–derived MSCs (hPMSCs) to induce generation of CD4+IL-10+IFN-γ+ T cells in vitro and in the humanized xenogenic GVHD NOD/SCID model. The results showed that the percentages of CD4+IL-10+IFN-γ+ T cells were significantly increased in activated human PBMC from both healthy donors and GVHD patients with hPMSCs and in the liver and spleen of hPMSC-treated GVHD mice, and the level of CD4+IL-10+IFN-γ+ T cells in the liver was greater than that in the spleen in hPMSC-treated GVHD mice. The serum level of IL-27 decreased and the symptoms abated in hPMSC-treated GVHD. Further, in vitro results showed that IL-27 promoted the regulatory effects of hPMSCs by enhancing the generation of CD4+IL-10+IFN-γ+ T cells from activated PBMC. Activation occurred through increases in the expression of programmed death ligand 2 (PDL2) in hPMSCs via the JAK/STAT signaling pathway. These findings indicated that hPMSCs could alleviate GVHD mice symptoms by upregulating the production of CD4+IL-10+IFN-γ+ T cells in the spleen and liver and downregulating serum levels of IL-27. In turn, the ability of hPMSCs to induce the generation of CD4+IL-10+IFN-γ+ T cells could be promoted by IL-27 through increases in PDL2 expression in hPMSCs. The results of this study will be of benefit for the application of hPMSCs in clinical trials.

7 September 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
YWYueming Wang
Yueming Wang
NZNannan Zhao
Nannan Zhao
YXYanlei Xiong
Yanlei Xiong
JZJiashen Zhang
Jiashen Zhang
DZDongmei Zhao
Dongmei Zhao
YXYanlian Xiong
Yanlian Xiong
Red blood cells (RBCs) are susceptible to sustained free radical damage during circulation, while the changes of antioxidant capacity and regulatory mechanism of RBCs under different oxygen gradients remain unclear. Here, we investigated the changes of oxidative damage and antioxidant capacity of RBCs in different oxygen gradients and identified the underlying mechanisms using an in vitro model of the hypoxanthine/xanthine oxidase (HX/XO) system. In the present study, we reported that the hypoxic RBCs showed much higher oxidative stress injury and lower antioxidant capacity compared with normoxic RBCs. In addition, we found that the disturbance of the recycling process, but not de novo synthesis of glutathione (GSH), accounted for the significantly decreased antioxidant capacity of hypoxic RBCs compared to normoxic RBCs. We further elucidated the underlying molecular mechanism by which oxidative phosphorylation of Band 3 blocked the hexose monophosphate pathway (HMP) and decreased NADPH production aggravating the dysfunction of GSH synthesis in hypoxic RBCs under oxidative conditions.